Role of biomarkers in the study and management of inflammatory bowel disease: a “non systematic” review
https://www-ncbi-nlm-nih-gov.eresources.mssm.edu/pubmed/25222663
Sachar DB; Biomarkers Task Force of the IOIBD.
Inflamm Bowel Dis. 2014 Dec;20(12):2511-8.
Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
Hospitalisations and surgery in Crohn’s disease.
Gut. 2012 Apr; 61(4):622-9.
Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV Jr, Tysk C, O’Morain C, Moum B, Colombel JF , Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
Geographic variability of environmental risk factors in inflammatory bowel disease.
Gut. 2013 Apr; 62(4):630-49.
Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease
Inflamm Bowel Dis. In press.
D’Haens G, Feagan B, Colombel JF, Sandborn WJ, Reinisch W, Rutgeerts P, Carbonnel F, Mary JY, Danese S, Fedorak RN, Hanauer S, Lémann M; International Organization for Inflammatory Bowel Diseases IOIBD and the Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organization ECCO.
Challenges to the design, execution and analysis of randomized controlled trials for Inflammatory Bowel Diseases
Gastroenterology. 2012;143:1461-9.